30.17
1.11%
+0.38
After Hours:
30.17
Disc Medicine Inc stock is currently priced at $30.17, with a 24-hour trading volume of 208.19K.
It has seen a +1.11% increased in the last 24 hours and a +0.07% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $29.85 pivot point. If it approaches the $30.32 resistance level, significant changes may occur.
Previous Close:
$29.79
Open:
$29.92
24h Volume:
208.19K
Market Cap:
$743.56M
Revenue:
-
Net Income/Loss:
$-76.43M
P/E Ratio:
-7.6191
EPS:
-3.9598
Net Cash Flow:
$-73.55M
1W Performance:
+6.47%
1M Performance:
+0.07%
6M Performance:
-36.58%
1Y Performance:
-1.67%
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
-
Address
321 Arsenal Street, Suite 101, Watertown
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
Jun-07-23 | Initiated | H.C. Wainwright | Buy |
May-17-23 | Initiated | Raymond James | Outperform |
Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
Apr-21-23 | Initiated | Stifel | Buy |
Apr-20-23 | Initiated | Morgan Stanley | Overweight |
Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Wall Street Breakfast: The Week Ahead
Seeking Alpha
Wall Street Breakfast: The Week Ahead
Seeking Alpha
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Zacks Investment Research
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
Zacks Investment Research
Top 3 Health Care Stocks You'll Regret Missing This Month
Benzinga
Gold Gains 1%; CXApp Shares Spike Higher
Benzinga
Disc Medicine Inc Stock (IRON) Financials Data
Disc Medicine Inc (IRON) Net Income 2024
IRON net income (TTM) was -$76.43 million for the quarter ending December 31, 2023, a -63.22% decrease year-over-year.
Disc Medicine Inc (IRON) Cash Flow 2024
IRON recorded a free cash flow (TTM) of -$73.55 million for the quarter ending December 31, 2023, a -73.46% decrease year-over-year.
Disc Medicine Inc (IRON) Earnings per Share 2024
IRON earnings per share (TTM) was -$3.49 for the quarter ending December 31, 2023, a +92.24% growth year-over-year.
Disc Medicine Inc Stock (IRON) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
White William Richard | Director |
May 01 '24 |
Sale |
28.63 |
201 |
5,755 |
0 |
White William Richard | Director |
Apr 11 '24 |
Option Exercise |
4.91 |
2,560 |
12,581 |
2,560 |
White William Richard | Director |
Apr 11 '24 |
Sale |
31.80 |
2,560 |
81,407 |
0 |
Savage William Jacob | Chief Medical Officer |
Apr 10 '24 |
Option Exercise |
2.65 |
21,870 |
57,956 |
43,405 |
Bitterman Kevin | Director |
Mar 05 '24 |
Sale |
73.50 |
26,157 |
1,922,540 |
677,503 |
Bitterman Kevin | Director |
Jan 23 '24 |
Sale |
67.65 |
102,500 |
6,934,125 |
198,326 |
Atlas Venture Fund X, L.P. | 10% Owner |
Jan 23 '24 |
Sale |
67.65 |
102,500 |
6,934,125 |
198,326 |
Atlas Venture Fund X, L.P. | 10% Owner |
Jan 23 '24 |
Sale |
67.65 |
47,500 |
3,213,375 |
1,402,186 |
Atlas Venture Fund X, L.P. | 10% Owner |
Jan 10 '24 |
Sale |
64.00 |
30,000 |
1,920,000 |
1,449,686 |
Bitterman Kevin | Director |
Jan 10 '24 |
Sale |
64.00 |
20,000 |
1,280,000 |
786,160 |
About Disc Medicine Inc
Disc Medicine Opco Inc, a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Cap:
|
Volume (24h):